Invenomic Capital Management’s Bristow Group VTOL Stock Holding History

Invenomic Capital Management’s Portfolio VTOL Stock Details VTOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-132,596	Closed	-$4.78M	–	173
2025 Q3	$4.78M	Buy	132,596 +18,003	+16%	+$661K	0.23%	105
2025 Q2	$3.78M	Buy	+114,593	New	+$3.46M	0.21%	113
2022 Q2	–	Sell	-24,260	Closed	-$757K	–	187
2022 Q1	$757K	Buy	24,260 +937	+4%	+$32.1K	0.08%	140
2021 Q4	$739K	Sell	23,323 -8,776	-27%	-$296K	0.16%	121
2021 Q3	$1.02M	Buy	32,099 +1,013	+3%	+$29.6K	0.33%	86
2021 Q2	$796K	Buy	+31,086	New	+$840K	0.19%	89

Other funds holding VTOL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SAAM

Solus Alternative Asset Management Summit, New Jersey $342M AUM 36.47% 1-Year Est. Return

SDIC

South Dakota Investment Council Sioux Falls, South Dakota $5.84B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Invenomic Capital Management's VTOL Position: Q4 2025 in Review

Invenomic Capital Management sold out of Bristow Group (VTOL) in Q4 2025, closing a stake of 132,596 shares — an estimated $4.78M sold.

Invenomic Capital Management first reported a position in VTOL in Q2 2021 and held it in 6 quarters. The position peaked at $4.78M in Q3 2025. 196 funds tracked by Wall St. Rank hold VTOL as of Q4 2025.

Invenomic Capital Management reported no remaining Bristow Group position as of Q4 2025 after selling out during the quarter.
Invenomic Capital Management sold 132,596 Bristow Group shares in Q4 2025, an estimated $4.78M.
Invenomic Capital Management first reported a position in Bristow Group in Q2 2021 and held it in 6 quarters.
Invenomic Capital Management's Bristow Group position peaked at $4.78M in Q3 2025.
196 funds tracked by Wall St. Rank held Bristow Group as of Q4 2025.

Based on Invenomic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.